Archive · 6 Aug 2025
Welcure Drugs Stock Surges After Stellar Q1 FY26 Results
Imagine a company called Welcure Drugs, which makes and sells medicine, had a really good three months!
Their stock price went up because they made more money.
They earned Rs 23.29 crore in profit, which is a lot more than the previous quarter.
They also made a lot more money overall, thanks to some big deals where they helped international clients buy supplies.
The company changed how they do business and seems to be doing very well.
In the past few years, the company's stock has given big returns to those who invested in it.
Welcure Drugs and Pharmaceuticals Ltd. shares hit the upper circuit after a strong Q1 FY26 result.
The stock price increased by 5% on the BSE.
The company's net profit for the quarter ending June 2026 was Rs 23.29 crore.
Revenue from operations rose to Rs 299.91 crore in Q1FY26.
The growth was driven by seven export-sourcing assignments.
- Who
- Welcure Drugs and Pharmaceuticals Ltd.
- What
- Welcure Drugs and Pharmaceuticals Ltd.'s stock price increased after a strong financial performance.
- When
- The stock price increased on Wednesday, August 6, 2025, after Q1 FY26 results.
- Where
- The stock rose on the BSE.
- Why
- Due to a strong Q1 FY26 result, including increased net profit and revenue from export-sourcing assignments.
- Stock Movement
- 5% gain on BSE
- Market Capitalisation
- Rs 114 crore (approx.)
- Net Profit (Q1FY26)
- Rs 23.29 crore
- Revenue from Operations (Q1FY26)
- Rs 299.91 crore
- Business Model
- Fee-based, asset-light model
- Established
- 1992
- Headquarters
- New Delhi